More specifically, an increase in the CSF levels of C1s (38), C1q (38), C4 (45), clusterin (39, 48, 49), complement receptor 1 (CR1) (45) and factor H (fH) (41) has been reported in AD patients compared to healthy controls (HC) and/or MCI. This evidence concerns the gene CR1 and Alzheimer disease.